Clinical Trial Update: Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating de-intensification of adjuvant therapy for HPV-related, p16-positive oropharyngeal cancer; study terminated with results posted in 2020…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer
• Oropharyngeal Neoplasms

Snippet

Sponsor: Washington University School of Medicine | Conditions: Oropharyngeal Neoplasms | Phase 3 | Status: TERMINATED | Results posted: 2020-11-10